NCT04868864|Unknown
The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study
COREG
Loading search results
COREG
Sponsor study identifier
observational
200
1 country
1
Study Start
May 15, 2021
Actual (reported)Primary Completion
September 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Radiological and lung function recovery following Covid-19 infection.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 24, 2021
Actual (reported)May 3, 2021
Actual (reported)May 15, 2021
Actual (reported)September 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Pulmonary changes on LDCT Scan
Identify pulmonary changes utilizing LDCT chest to characterize the pulmonary recovery trajectory of survivors of COVID-19.
Through study completion, an average of 9 months
DLCO
Through study completion, an average of 9 months
TLC
Through study completion, an average of 9 months
FEV1
Through study completion, an average of 9 months
FVC
Through study completion, an average of 9 months
COVID-19 patients with radiographic changes on CXR or CT which had not resolved or had persistent hypoxia due to COVID-19 at the time of discharge will be enrolled. All participants will undergo a LDCT and PFT.
Participants with abnormalities on LDCT and or PFT will be invited to continue with a follow-up sub-study. This will involve follow up with repeated LDCT and PFT at subsequent time points to monitor and manage the abnormalities detected until the abnormalities fully resolve or to the last time point at 9 months of the study.
Non-enhanced LDCT scans of the thorax will be taken using standard technology on helical CT system
Standard pulmonary function testing will be conducted by trained pulmonary technologists following the American Thoracic Society standards
COVID-19 patients discharged from hospitals with radiographic and clinical evidence of COVID-19 pneumonia during hospitalization.
Juravinski Hospital
Hamilton, Ontario, L8V 1C3, Canada
Mylinh Duong, MD
McMaster University Hospital
First Submitted
April 24, 2021
First Posted
May 3, 2021
Study Start
May 15, 2021
Actual (reported)Primary Completion
September 30, 2022
Estimated (date passed)Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 25, 2021
Record last verified: 2021-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: